» Articles » PMID: 35464038

Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia

Overview
Journal Front Nutr
Date 2022 Apr 25
PMID 35464038
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neural tube defects (NTDs) are prevalent congenital defects associated with pre-pregnancy diet with low levels of maternal folate. They are linked to severe morbidity, disability, and mortality, as well as psychological and economic burdens.

Objective: The goal of this study was to determine the levels of folate, vitamin B12, and homocysteine in the blood of women who had a pregnancy impacted by NTDs.

Subjects And Methods: A hospital-based case-control study was undertaken between September 2019 and August 2020. The study comprised a total of 100 cases and 167 controls. Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of folate, vitamin B12, and homocysteine in the serum.

Results: Only 39% of the cases and 54.5% of control mothers reported periconceptional use of folic acid/multivitamin, which indicated a statistically significant difference ( = 0.014). Logistic regression indicated that periconceptional use of folic acid/multivitamin was associated with NTDs ( = 0.015, OR = 1.873, 95% CI: 1.131-3.101). We found that 57% of the cases and 33.5% of controls, as well as 43% of cases and 20.4% of controls had serum folate and vitamin B12 levels below the cut-off value, respectively. Twenty-seven percent of the cases and 6.6% of controls had hyperhomocysteinemia (HHcy). The median concentrations of folate, vitamin B12, and homocysteine in cases and controls were 4.78 and 8.86 ng/ml; 266.23 and 455 pg/ml; 13.43 and 9.7 μmol/l, respectively. The median concentration of folate ( < 0.001) and vitamin B12 ( < 0.001) were significantly lower in the cases than controls, while the homocysteine concentration ( < 0.001) was significantly lower in the controls than cases. Folate [OR (95% CI) = 1.652 (1.226-2.225; = 0.001)], vitamin B12 [OR (95% CI) = 1.890 (1.393-2.565; < 0.001], and homocysteine [OR (95% CI) = 0.191 (0.09-0.405; < 0.001)] levels were associated with NTDs.

Conclusion: Folate and vitamin B12 are deficient in both cases and control mothers. The lower levels of folate and vitamin B12 with an elevated homocysteine level in NTD-affected pregnancy may be an indication that these biochemical variables were risk factors for NTDs. Folate/multivitamin supplementation and/or food fortification should be promoted.

Citing Articles

Maternal Smoking during Pregnancy and its effects on Neural Tube Defects.

Elahi Z, Hassanzadeh F, Satarzadeh M Iran J Child Neurol. 2024; 18(3):103-115.

PMID: 38988851 PMC: 11231676. DOI: 10.22037/ijcn.v18i3.41499.


Dietary vitamin B6 intake and stroke are negatively associated in adults: A cross-sectional study from the NHANES.

Wang C, Li B, Zhu Q, Zhang Q, Xie Z, Xie H Heliyon. 2024; 10(10):e31125.

PMID: 38778939 PMC: 11109891. DOI: 10.1016/j.heliyon.2024.e31125.


Birth prevalence and risk factors of neural tube defects in Ethiopia: a systematic review and meta-analysis.

Tesfay N, Hailu G, Habtetsion M, Woldeyohannes F BMJ Open. 2023; 13(11):e077685.

PMID: 37940152 PMC: 10632862. DOI: 10.1136/bmjopen-2023-077685.


The Impact of Maternal Gut Microbiota during Pregnancy on Fetal Gut-Brain Axis Development and Life-Long Health Outcomes.

Sajdel-Sulkowska E Microorganisms. 2023; 11(9).

PMID: 37764043 PMC: 10538154. DOI: 10.3390/microorganisms11092199.


Folate deficiency among women of reproductive age in Ethiopia: A systematic review and meta-analysis.

Gebremichael B, Roba H, Getachew A, Tesfaye D, Asmerom H PLoS One. 2023; 18(5):e0285281.

PMID: 37155667 PMC: 10166565. DOI: 10.1371/journal.pone.0285281.


References
1.
Finkelstein J, Layden A, Stover P . Vitamin B-12 and Perinatal Health. Adv Nutr. 2015; 6(5):552-63. PMC: 4561829. DOI: 10.3945/an.115.008201. View

2.
Kancherla V, Koning J, Biluts H, Woldemariam M, Kibruyisfaw Z, Belete A . Projected impact of mandatory food fortification with folic acid on neurosurgical capacity needed for treating spina bifida in Ethiopia. Birth Defects Res. 2020; 113(5):393-398. PMC: 7986934. DOI: 10.1002/bdr2.1857. View

3.
Wallingford J, Niswander L, Shaw G, Finnell R . The continuing challenge of understanding, preventing, and treating neural tube defects. Science. 2013; 339(6123):1222002. PMC: 3677196. DOI: 10.1126/science.1222002. View

4.
Afman L, van der Put N, Thomas C, Trijbels J, Blom H . Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. QJM. 2001; 94(3):159-66. DOI: 10.1093/qjmed/94.3.159. View

5.
Blencowe H, Kancherla V, Moorthie S, Darlison M, Modell B . Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann N Y Acad Sci. 2018; 1414(1):31-46. DOI: 10.1111/nyas.13548. View